AzTrials
AzTrials

Intubation,EndotrachealNCT00912990

Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet

A study testing Cisatracurium and Normal saline in people with Intubation,Endotracheal, run by Rady Children's Hospital, San Diego at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The investigators' primary specific aims are to demonstrate that: 1. Pediatric patients with normal airways, undergoing elective surgical procedures, can be successfully intubated when deeply sedated, without the use of muscle relaxants using the Shikani Optical Stylet. 2. Read more about this study

Who is it for?
Ages 6 months to 17 years
Conditions the study is for
Intubation,Endotracheal
What is being tested?
Cisatracurium and Normal saline
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteUnited States
Study dates
Jan 2007to Feb 2008
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 6 months of age to 17 years of age (not yet 18)
  • Male or female
  • English or Spanish speaking
  • Normal airway (Mallampati Classification )
  • American Society of Anesthesiology Physical Status Classification I or II
  • Elective surgical procedure expected to last at least 45 minutes in length
  • Written informed consent/assent for participation given by the parent legal guardian and subject (if applicable)

Who cannot join

  • < 6 months of age, > 17 years of age
  • Difficult airway (Mallampati Classification)
  • History of previous difficult intubation, suspected abnormal airway: *micrognathia
  • facial trauma
  • airway tumor
  • epiglottitis
Show all 10Show fewer
  • retropharyngeal abscess
  • foreign body, etc.
  • Scheduled for non-elective, emergent OR procedure
  • Parent, legal guardian, or subject is unavailable or unwilling to consent for study participation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Rady Children's Hospital

    San Diego, California, 92123

Other trials in United States

About this study

The investigators' primary specific aims are to demonstrate that:

  1. Pediatric patients with normal airways, undergoing elective surgical procedures, can be successfully intubated when deeply sedated, without the use of muscle relaxants using the Shikani Optical Stylet.
  2. Shikani intubation of pediatric patients is equally effective in children that are deeply sedated or paralyzed as evidenced by a non-significant difference in:
  • Time to intubation (defined as no more than a 30 second time difference between the two groups);
  • Incidence of adverse events.
Being tested
Cisatracurium, Normal saline
Keywords
Pediatric

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CisatracuriumDrug

    Also called Nimbex

    One intravenous dose: 0.2mg/kg/dose

  • Normal salineDrug

    One Intravenous dose

Study groups in NCT00912990
Study groupRoleWhat they receive
Normal salinePlacebo comparatorNormal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg
Receives: Drug: Normal saline
CisatracuriumActive comparatorSubjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.
Receives: Drug: Cisatracurium

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to Intubation

    Time to intubation was defined as the time (seconds) required to verify three breaths on an end-tidal carbon dioxide monitor.

    Measured: Confirmed by the visualization of three carbon dioxide waveforms.

Secondary outcomes (1)
  1. The Number of Adverse Events

    The number of occurrences of each event. One subject may have multiple adverse events.

    Measured: Recorded from the start of the intubation procedure to the time of successful endotracheal intubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2009 (estimated)
  2. Study startJan 2007
  3. Primary completionFeb 2008
  4. Study completionFeb 2008

Why it stopped: Adequate subjects numbers not enrolled in study timeframe.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00912990
Sponsor's protocol ID
11672
Other IDs
06104C
Status last verified
Aug 2020
First submitted
1 Jun 2009
Last updated
18 Aug 2020
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Cisatracurium and Normal saline in people with Intubation,Endotracheal, run by Rady Children's Hospital, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 12 Aug 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to Intubation (time frame: Confirmed by the visualization of three carbon dioxide waveforms.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2020; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in